![photo of mri scans of brain](https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/newsletter/alzheimers_nl_module_1800x1200.jpg)
With no cure in sight, any new approval ushers in hope, including with an agent like Leqembi that slowed progression of the disease an average of 27% in research.
from WebMD Health https://ift.tt/zL9QvBg
With no cure in sight, any new approval ushers in hope, including with an agent like Leqembi that slowed progression of the disease an average of 27% in research.
0 comments:
Post a Comment